全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Extreme Hyperferritinemia in a Filipino Male Patient with Adult Onset Still’s Disease: A Case Report

DOI: 10.4236/ojra.2022.124013, PP. 119-127

Keywords: Still’s Disease, Hyperferritinemia, Autoimmune, Tocilizumab, Case Report

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Elevated serum ferritin is more commonly due to reactive causes such as infection, hepatic disorders, rheumatologic conditions, and malignancy than true iron overload. Extreme hyperferritinemia (>10,000 ng/mL), on the other hand, should prompt consideration of rare conditions such as adult-onset Still’s disease (AOSD) or hemophagocytic lymphohistiocytosis. This paper aims to present the case of the highest reported extreme hyperferritinemia (actual level 256,000 ng/mL) in a patient eventually diagnosed with adult onset Still’s Disease (AOSD). Case Presentation: A 55-year-old male, Filipino, was admitted due to acute onset fever and shortness of breath. He was initially assessed to have community-acquired pneumonia and a suspect for coronavirus disease 2019 (COVID-19), hence inflammatory markers were requested. Ferritin was notably elevated at 44,255 ng/mL. He eventually tested negative for COVID-19 RT-PCR. He was investigated for other causes of markedly elevated ferritin levels. His complete blood count (CBC) only showed leukocytosis with no peripheral blasts, iron level and liver function tests were normal, HIV immunoassay was negative, ANA was 1:80 speckled with normal complement level, rheumatoid factor negative, and positron emission tomography (PET) scan revealed presence of lymphadenopathies and did not show solid tumors. He was treated for urinary tract infection and pneumonia but still had intermittent fever and increasing ferritin trend, with the highest documented level at 256,000 ng/mL. Fulfilling the Yamaguchi criteria, he was managed as a case of severe AOSD and received tocilizumab. He had lysis of fever and decreasing trend of ferritin levels thereafter, with ferritin level of 34,184 ng/mL three weeks after tocilizumab infusion. He was discharged and improved with prednisone and methotrexate as home medications. Conclusion: To our knowledge, the highest level of extreme hyperferritinemia recorded in literature as of 2016 is 143,931 ng/mL, which was associated with hematologic malignancy. This case documents the highest noted

References

[1]  Sackett, K., Cunderlik,, M., Sahni, N., et al. (2016) Extreme Hyperferritinemia: Causes and Impact on Diagnostic Reasoning. American Journal of Clinical Pathology, 145, 646-650.
https://doi.org/10.1093/ajcp/aqw053
[2]  Hernandez, A.T.S., Magbitang, A.T.D., Tee, K.D., Uy, P., Amante, E.J., Lorenzo, J.P. and Tee, M.L. (2013) A Rare Cause of Fever, Rashes, and Arthritis: A Report of Three Cases of Adult-Onset Still’s Disease in the Philippine General Hospital. Philippine College of Physicians, Article No. 62, 2013-2014.
[3]  Durano II, R. and Robles, J. (2021) An Unusual Cause of Fever, Rash, and Joint Pain: A Case Report of Adult Onset Still’s Disease. Philippine Journal of Internal Medicine, 58, 153-157.
[4]  Cuenco, F.M.T. and Navarra, S.V. (2021) Tocilizumab for Refractory Adult-Onset Still’s Disease: Report of Three Cases. Philippine Journal of Internal Medicine, 58, 4.
[5]  Fautrel, B., Le Moël, G., Saint-Marcoux, B., Taupin, P., Vignes, S., Rozenberg, S., Koeger, A.C., Meyer, O., Guillevin, L., Piette, J.C. and Bourgeois, P. (2001) Diagnostic Value of Ferritin and Glycosylated Ferritin in Adult Onset Still’s Disease. The Journal of Rheumatology, 28, 322-329.
[6]  Lee, D.W., Gardner, R., Porter, D.L., Louis, C.U., Ahmed, N., Jensen, M., Grupp, S. A. and Mackall, C.L. (2014) Current Concepts in the Diagnosis and Management of Cytokine Release Syndrome. Blood, 124, 188-195.
https://doi.org/10.1182/blood-2014-05-552729
[7]  Castañeda, S., Martínez-Quintanilla, D., Martín-Varillas, J.L., García-Castañeda, N., Atienza-Mateo, B. and González-Gay, M.A. (2019) Tocilizumab for the Treatment of Adult-Onset Still’s Disease. Expert Opinion on Biological Therapy, 19, 273-286.
https://doi.org/10.1080/14712598.2019.1590334
[8]  Zeng, T., Zou, Y.Q., Wu, M.F. and Yang, C.D. (2009) Clinical Features and Prognosis of Adult-Onset Still’s Disease: 61 Cases from China. The Journal of Rheumatology, 36, 1026-1031.
https://doi.org/10.3899/jrheum.080365
[9]  Wang, M.Y., Jia, J.C., Yang, C.D. and Hu, Q.Y. (2019) Pathogenesis, Disease Course, and Prognosis of Adult-Onset Still’s Disease: An Update and Review. Chinese Medical Journal, 132, 2856-2864.
https://doi.org/10.1097/CM9.0000000000000538
[10]  Ruscitti, P., Cipriani, P., Masedu, F., et al. (2016) Adult-Onset Still’s Disease: Evaluation of Prognostic Tools and Validation of the Systemic Score by Analysis of 100 Cases from Three Centers. BMC Medicine, 14, Article No. 194.
https://doi.org/10.1186/s12916-016-0738-8
[11]  Bhargava, J. and Panginikkod, S. (2022) Still Disease. [Updated 2020 Jul 10]. In: StatPearls. StatPearls Publishing Treasure Island (FL), 2021 Jan.
https://www.ncbi.nlm.nih.gov/books/NBK538345/
[12]  Mehta, B.Y., Ibrahim, S., Briggs, W. and Efthimiou, P. (2019) Racial/Ethnic Variations in Morbidity and Mortality in Adult Onset Still’s Disease: An Analysis of National Dataset. Seminars in Arthritis and Rheumatism, 49, 469-473.
https://doi.org/10.1016/j.semarthrit.2019.04.004

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133